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ABSTRACT
Sin3 is the central component of a multisubunit
co-repressor complex. A number of DNA-binding
proteins are targeted by the Sin3 complex to chro-
matin through association with its paired amphi-
pathic helix (PAH) domains. Here, we performed a
yeast two-hybrid screening using a peptide aptamer
library and identified peptides that interact with
either PAH1 or PAH2. Analysis of PAH2 interacting
peptides uncovered motifs similar to previously
characterized PAH2 interacting proteins, Mad,
Ume6 and kruppel-like members, while analysis of
PAH1 interacting peptides revealed an LXXLL motif.
In addition, a tandem affinity purification (TAP)-
tagging approach of Sin3b resulted in the isolation
of known and novel interactors amongst which
neural retina leucine (NRL) zipper. Strikingly, one
of the identified PAH2 interacting peptide showed
strong resemblance to the NRL region amino acids
125–150. Direct association between PAH2 and NRL
was shown and NRL(125–150) mediated transcrip-
tional repression in reporter assays. Finally, we
reveal that PAH1 and PAH2 amino acids 7, 14 and
39 shown previously to be important for Mad–PAH2
interaction, also play an important role in the
specificity of interaction between PAH1, PAH2 and
identified aptamers. Our results provide novel
insights into the molecular determinant of the
specificity of PAH1 and PAH2 for their interacting
partners.
INTRODUCTION
Transcriptional regulation is central to many cellular func-
tions including differentiation and development. In eukary-
otes, alteration of chromatin structure plays an integral role
in gene regulation. Such chromatin changes occur on core
histone tails at a post-translational level and are induced
by different classes of enzymes including histone acetyl
transferases (HAT) or histone deacetylases (HDAC) (1,2).
Recruitment of HAT complexes to genes generally results
in transcription activation while recruitment of HDACs
results in transcriptional repression (3,4). The Sin3 protein
is an evolutionary conserved repressor that is part of
1.2 MDa multi-protein co-repressor complex associated
with HDAC activity. The core subunits of the Sin3 complex
include HDAC1, HDAC2, RbAp46/48, RBP1, SAP130,
BRMS1, SDS3, SAP30 and SAP18 (5–11).
Sin3 contains four conserved imperfect repeats of
100 amino acids termed paired amphipathic helix (PAH)
domains which are protein–protein interaction modules for
an array of DNA-binding transcriptional repressors (12).
PAH1 has been reported so far to interact with Opi1, Pf1,
NRSF, N-CoR and SMRT (13–17). The PAH2 domain covers
a broad range of interactions including Mad protein family
members, Sp1-like repressor poteins, HBP1, Pf1 and yeast
Ume6 (14,18–23).
The interaction of Sin3 with the tumour suppressor Mad
is particularly well studied. The ability of Mad to inhibit
cell proliferation and to repress transcription is dependent
on an N-terminal N8IQMLLEAADYLE20 domain named
SID (Sin3 interacting domain) (22,24). In nuclear magnetic
resonance experiments, Mad SID folds as an amphipatic
helix and contacts the PAH2 domain of Sin3 which folds as
a four-helix bundle (25–27). A recent study from Swanson
et al. (23) revealed a reverse N-terminal to C-terminal ori-
entation of the HBP1 SID amphipatic helix in contact with
PAH2 as compared with the Mad SID. Furthermore, molecu-
lar dynamic simulation has suggested that TIEG2 SID binds
PAH2 in a different orientation than the Mad SID, suggesting
multiple ways to interact with PAH2 (23,28).
Initial attempts to identify a SID consensus sequences for
Mad family members revealed the following degenerated seq-
uence: jZZjjXAAXXjnXXn with X for any non-proline
residues, j for bulky hydrophobic residues and n for nega-
tively charged residues (25–27). Other studies have reported
the SID of SP1-like members with PAH2 as jjXAAXXj.
Despite a wealth of information on PAH2 and interacting
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SIDs, PAH1 remains poorly characterized and the identifica-
tion of a PAH1 interaction motif has not been reported.
Here, we screened peptide aptamer libraries to identify
PAH1 and PAH2 interacting peptides. Different motifs inter-
acting with PAH1 and PAH2 are presented. We show that
binding of the identified aptamers to the PAH1 or PAH2
domains is affected by PAH1 and PAH2 mutations shown
previously to be important for an interaction with the Mad
SID (29). A complementary approach using TAP-tagging of
mSin3b revealed the transcription factor NRL, a neural retina
leucine zipper protein which contains an amino acid sequence
similar to one of the PAH2 aptamers, in addition to proteins
that are part of the core Sin3/HDAC complex.
MATERIALS AND METHODS
Cloning and binding assay
Oligos containing a BamHI restriction site overhang followed
by P1-1 EGDWLFFVLLVGLL or P1-8 SAAMGSAEFEAL-
VALLFLSEE encoding sequences and an EcoRI restriction
site overhang were annealed, phosphorylated and ligated in
frame to the GB1 domain of streprococcal protein G using
BamHI and EcoRI site of pGEV2 plasmid. A fragment
encompassing mSin3b was subcloned from pvzmSin3b (20)
into EcoRI and BamHI site from pZXN. pZXN has been
described in another study and contains one ProtA domain,
two TEV cleavage sites and an myc epitope. NRL was ampli-
fied by PCR from plasmid pcDNA4-NRL using a forward
primer containing an EcoRI restriction site overhang with a
myc tag (MEQKLISEEDL) in combination with a reverse
primer containing a BamH1 restriction site and after digestion
by EcoRI/BamHI was ligated into pSG5 (Stratagene) (30).
NRL was also amplified with a forward primer containing
an EcoRI restriction site overhang in combination with a
reverse primer containing an HindIII restriction site overhang
and after digestion by EcoRI/HindIII, the digested product
was ligated into PM to generate a GAL4 fusion protein
with NRL. NRL SID was generated by annealing oligos con-
taining an EcoRI site overhang followed by HVQLAERFS-
DAALSMSVRELNR encoding sequence and an HindIII
restriction site overhang. After annealing and phosphoryla-
tion, NRL SID was ligated in frame to GAL4 of PM plasmid
to generate PM-NRL SID. All constructs and positive
aptamers vectors were validated by DNA sequencing.
The P1-1 and P1-8 or mutant aptamers fused to the GB1
domain of streptococcal protein G was prepared as described
previously (25). GST–PAH1 (amino acids 34–108) and GST–
PAH2 (amino acids 148–252) and their respective mutants at
position 7, 14 and 39 were expressed and purified as
described previously (31).
GST–PAH1 or PAH2 (10 mg) and their respective mutants
were incubated with protG-P1-1 or protG-P1-8 and bound
to IgG–Sepharose (Pharmacia) in 150 mM NaCl, 0.1%
NP-40 and 20 mM Tris (pH 7.6). Beads were washed three
times with the same buffer. Bound proteins were eluted
with 0.1 M glycine (pH 2.6), separated by SDS gel electro-
phoresis and stained using coomassie blue.
mycNRL (40 mg) was transfected in 293 HEK (human
embryonic kidney) cells on a 14 cm dish using the calcium
phosphate method. Whole-cell extract was prepared 36 h
after transfection as described perviously (32). Subsequently,
extracts were incubated in 3 vol of IPP150 (10 mM Tris,
150 mM NaCl, 0.1% NP-40 and 0.5 mM EDTA) and equal
amounts (2 mg) of GST–PAH1 or GST–PAH2 and GST–
Sepharose 4B (Amersham). After 1 h incubation at 4C
on a rotating wheel, beads were washed three times with
20 beads volumes of IPP150. Bound fraction was subjected
to SDS–PAGE and western blotting using a-myc monoclonal
antibody (9E10).
Reporter assays
Transfection was performed in 293 HEK cells using Lipofec-
tamine 2000 according to the manufacturer’s protocol (Invit-
rogen). pGL5, a firefly luciferase reporter plasmid (400 ng),
under the control of five GAL4-binding sites and pRL-tk
(Promega) (400 ng), a Renilla luciferase control plasmid,
was cotransfected with either PM (GAL4 DBD plasmid;
3 mg) or PM-NRL (3 mg) and PM-NRL SID (3 mg). Total
amount of DNA was adjusted to 4 mg with pBS plasmid
(Stratagene). The cells were harvested 48 h after transfection.
Lysis and measurement of Renilla and firefly luciferase activ-
ities were performed with the dual-Luciferase Reporter
assay system according to the manufacturer’s protocol (Pro-
mega). The 293 HEK cells were treated with trichostatin A
(TSA; 100 ng/ml) 24 h before harvesting.
Yeast two-hybrid screening
Yeast strain KF1 (MATa trp1-901,leu2-3,112 his3-200 gal4D
gal80D LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ
SPAL10-URA3) was used for the screening. As a bait the
PAH1 or the PAH2 domain of mSin3b were fused in frame
with the GAL4 DNA-binding domain in vector pcp97 des-
cribed previously (29). The yeast prey vector padTRX
encodes the Escherichia coli thioredoxin A (trxA) gene
fused to the Gal4 activation domain. The 20 amino acid
randomized peptide library was inserted in the RsrII site of
trxA which corresponds to a constrain loop and was estimated
to be of a complexity of 2 · 108 individual members (33).
KF1 containing a PAH1 or PAH2 bait was transformed
using LiAC method with the peptide aptamer expression
library and was first selected for growth on media lacking
adenine. Subsequently KF1 positive transformants were
replicas plated on media lacking histidine in the presence
of increasing concentration of the inhibitor 3-amino-triazole
(3AT) as indicated.
After rescue of the positive aptamer expression vectors, the
PAH binding specificity was established in the Saccha-
romyces cerevisiae Y190 (Clontech) strain using PAH1
and PAH2 mutants as described previously (29). Quantitative
b-galactosidase assay was performed using O-nitrophenyl b-
D-galatopyranoside (ONPG) as a substrate. Fresh transfor-
mants were grown overnight in 5 ml SD-leu-trp selective cul-
ture medium; 1.5 ml cells were concentrated five times in
buffer Z (60 mM Na2HPO4, 60 mM NaH2PO4, 10 mM KCl
and 1 mM MgSO4, pH 7.0). Cells were resuspended in
100 ml buffer Z and freeze thawed. Buffer Z (0.7 ml) supple-
mented with 50 mM b-mercaptoethanol and 160 ml (4 mg/ml)
ONPG was added to initiate the reaction. Incubations for
30 min up to 2 h were performed at 30C. Reactions were
stopped with 0.4 ml of 1 M Na2CO3. b-Galactosidase units
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were calculated according to the formula b-galactosidase
units (mmol ONPG · min1) ¼ 1000 · OD420/(time in
min · 0.1 · 5 · OD600). Experiments were repeated at least
three times and in triplicate.
RESULTS
Identification of PAH1 and PAH2 aptamers
The PAH2 domain of Sin3 associates with a number of
proteins and the interaction domains determine a tentative
consensus SID. A PAH1 interaction consensus has, however,
not been determined. Therefore, we performed a peptide
library screen to identify specific PAH1 and PAH2 interact-
ing peptides. We screened a random constrained 20mer
peptide library displayed on the active site loop of E.coli
thioredoxin (TRX) molecule fused to the Gal4 transcription
activation domain in a yeast two-hybrid assay. The PAH1
or the PAH2 domain of mSin3b were fused to the DNA-
binding domain of Gal4 (G4DBD) and used as baits. Inter-
action between baits and preys yields transactivation of the
reporter gene GAL1-HIS3 and consequent growth on media
lacking histidine. The relative strength of the interaction
was assessed by determining resistance to the histidine
biosynthesis inhibitor 3-amino-triazole (3AT). As a control
prey, we used the previously described Mad SID (G4AD-
TRX-Mad) known to specifically interact with PAH2 (29).
Mad SID combined with PAH2 supported growth of yeast
on media lacking histidine and supplemented with 50 mM
3AT whereas Mad SID combined with PAH1 did not support
growth. Thus, Mad specifically interacts with PAH2 in this
assay (Figure 1A). Screening 106 and 2 · 106 transformed
yeast clones for PAH1 and PAH2 interactors led to the isola-
tion of 8 and 11 different transformants, respectively
(Figure 1A and B). Transformants showed growth in the pres-
ence of 50 mM up to 100 mM 3AT for PAH1 aptamers
and from 10 mM up to 100 mM 3AT for PAH2 aptamers.
After isolation of the prey plasmid, the sequence of the pep-
tide insert was determined (Table 1).
The FXXLVXLL motif is a PAH1 interacting motif
To characterize the identified PAH1 aptamers we first
analysed their specificity. We retransformed each prey with
PAH2 or PAH1 in YN1 yeast strain and performed quantita-
tive b-galactosidase assay. Background levels were observed
for every PAH1 aptamer in combination with G4DBD–
PAH2, showing that interaction between PAH1 recovered
aptamers and PAH1 was specific (Figure 2A).
We reported previously that introduction of PAH2 residues
Phe7, Val14 and Gln39 at their corresponding position in
PAH1 enables a specific interaction with Mad, a PAH2 spe-
cific interacting protein and showed that PAH2 residues Phe7,
Val14 and Gln39 play an important role in determining the
specificity of the PAH2–Mad interaction. Assuming that
amino acids at the respective position in PAH1 play a similar
role in determining the specificity between PAH1 and PAH1
aptamers, we hypothesized PAH1 residues Val7, Leu14 and
Lys39 to be specific molecular determinants of PAH1–
PAH1 aptamers interaction. To test this assumption, we
assessed whether binding of the aptamers to PAH1 was
affected by mutating the amino acid Val7 and Leu14 into
Phe7 and Val14, respectively, as they appear in PAH2. All
PAH1 aptamers except P1-4 showed complete loss of interac-
tion upon mutation of L14V; aptamers that interacted weakly
with PAH1 were also strongly affected by the V7F mutation
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Figure 1. Identification of aptamers interacting with the PAH1 or the
PAH2 domain of mSin3b in a yeast two-hybrid screen. Yeast containing a
control Mad1 SID sequence (5–24) fused to GAL4AD in combination with
PAH2 fused to Gal4DBD is able to survive on media lacking histidine with
50 mM 3AT while yeast containing Mad1 and PAH1 fused to G4DBD was
not able to support growth. Yeast containing PAH1 aptamers (P1-1–P1-8)
(A) with a G4DBD-PAH1 or PAH2 aptamers (P2-1–P2-11) (B) with a
G4DBD-PAH2 (B) survived on media lacking histidine supplemented with at
least 50 mM 3AT.
Table 1. Sequence of peptide aptamers identified from a screening with a
G4DBD-PAH1 or G4DBD-PAH2 bait
Aptamers binding to the PAH1 domain of mSin3b
P1-1 EGDWLFFVLLVGLLa
P1-2 LACRCWRCVHTRVRLLWa
P1-3 VDVYGSFGLLWCFECFVSEC
P1-4 LWLLSEVSSVYGTa
P1-5 SLALYASIWLLAEHWPQGLI
P1-6 WSLTWVPLYVLTMCAYWRSL
P1-7 DRLSCFWCWWLVFLTHHAAG
P1-8 AAMGSAEFEALVALLFLCEE
Aptamers binding to the PAH2 domain of mSin3b
P2-1 NLGLLVLGSVCTFRLGLLa
P2-2 VDSAWAALLSVACCSLWGLV
P2-3 EGCVVVDWAAWVLVGYAAGW
P2-4 MPSSLNFGSFMGASLWGPLVIAFFLRFRRTGLFLLWVVa
P2-5 WWAWLSVKLGHSGDWLVSLF
P2-6 VVFLCFLDSLSCAVDAAGDD
P2-7 GVFFVFLLWTSMPSAESTSM
P2-8 SSPYCSSRWKILSFa
P2-9 FYLWMLSRGGSGPMLLQIVL
P2-10 CMWLMGHSMRLILIWCACMT
P2-11 VEHCDFCCTVAALVLMSRES
aIndicates a truncated peptide.
Nucleic Acids Research, 2006, Vol. 34, No. 14 3931
(Figure 2B). Despite an impaired interaction of PAH1 L14V
with PAH1 aptamers, PAH1 V7F L14V double mutant read-
ily associated with PAH1 aptamers suggesting that in a dou-
ble mutant context, V7F mutation partially suppressed the
critical effect of L14V mutation. We conclude that PAH1
Leu14 is a critical residue for binding of PAH1 aptamers in
our yeast two-hybrid assay.
P1-1 and P1-8 boosted relatively high levels of the reporter
gene activity and inspection of the amino acid sequence
revealed the shared motif FXXLVXLL (Figure 2C). Sec-
ondary structure prediction showed a preference for P1-1
and P1-8 to adopt an a-helix and a helical wheel projection
showed that the FXXLVXLL motif is placed on one surface
of the a-helix. Such a structural characteristic has also been
described in the SID of Mad family members that bind PAH2
(Figure 2D).
To corroborate and validate the interaction between PAH1
and P1-1 or P1-8, in vitro pull-down assay was performed.
We expressed and purified a fusion protein consisting
of the ProtG domain followed by P1-1 or P1-8 that was
incubated with Igg beads in the presence of GST–PAH1,
GST–PAH2 or GST–PAH1 mutants. A direct interaction
with PAH1 but not PAH2 was observed, thus confirming
the PAH1 domain specificity of the aptamers (Figure 3A).
The L14V point mutation in PAH1 impaired binding to
P1-1 and P1-8 while a modest decrease in binding was
observed with V7F, confirming and extending the yeast
two-hybrid observations. Furthermore substitution of Lys39
in PAH1 with Gln39, the amino acid present in PAH2 on
that position, abolished the interaction with P1-1 and P1-8.
As observed previously in yeast two-hybrid experiments,
PAH1 V7F L14V double mutants interacted with P1-1 and
P1-8 in contrast to PAH1 L14V single mutant which did
not associate with P1-1 and P1-8. This subtle difference sug-
gests that in a PAH1 V7F L14V context, PAH1 V7F mutation
suppressed the critical effect of PAH1 L14V mutation. Dou-
ble mutant V7F K39Q and triple mutant V7F L14V K39Q did
not associate with either P1-1 or P1-8. We conclude that
Leu14 and Lys39 in PAH1 are critical amino acids for inter-
action while Val7 may only have a stabilizing role.
To establish the importance of the proposed FXXLVXLL
motif for an interaction with PAH1, an alanine scan of
P1-8 was performed on the presumed conserved residues of
the postulated motif and tested in Igg pull-down assay with
GST–PAH1 (Figure 3B and C). Mutating Leu15 or Leu16
severely destabilized the interaction between the motif and
PAH1 while mutating Leu12 significantly enhanced binding.
Mutating Phe9 or Val13 displayed only minor effects. There-
fore Leu15 and Leu16 in P1-8 are critical for interacting with
PAH1 whereas Leu12 can be mutated into an alanine to
increase in vitro binding of P1-8 to PAH1.
Consistent with our findings a recent study described a
novel PAH1 interacting protein, SAP25, a component of
the Sin3 complex with a LXXLL motif that is also present
in the PAH1 aptamers P1-1 and P1-8 (Figure 2C) (34).
Specificity of PAH2 aptamers
The binding specificity of PAH2 peptide aptamers was
assessed as described for PAH1 (Figure 4A). Each of the
PAH2 aptamers displayed low level of interaction when
retransformed with PAH1, indicating that interaction between
PAH2 recovered aptamers and PAH2 was specific.
We have shown previously that introduction of PAH1
residues Val7 and Leu14 at their corresponding position in
PAH2 impairs interaction with Mad indicating that PAH2
residues Phe7 and Val14 play an important role in specificity
between PAH2 and Mad interaction (29). Therefore, we
assumed that PAH2 residues Phe7 and Val14 may also play
an important role in the specificity of interaction between
PAH2-specific aptamers and PAH2. The interaction between
PAH2 and the aptamers was assessed upon mutating
A
B
P1-1 P1-8
P1-1
P1-8
SAP25
Consensus               F X X L V X L L
C
D
Figure 2. Analysis of the interaction of PAH1 aptamers in vitro.
(A) PAH1 aptamers fused to G4AD were assayed in liquid culture to
examine b-galactosidase activity either in the presence G4DBD fused to
PAH1 and PAH2. (B) b-Galactosidase assay of PAH1 aptamers in the
presence of G4DBD fused to PAH1 single or double mutant V7F and L14V.
(C) Sequence alignment of P1-1 and P1-8 showing conservation of an
FXXLVXLL motif with SAP25. (D) Helical wheel of P1-1 and P1-8. Arrows
depict FXXLVXLL residues localized within one side of the helix in P1-1
or P1-8.
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conserved PAH2 residues Phe7 and Val14 to the correspond-
ing PAH1 residues Val7 and Leu14. F7V or L14V substitu-
tions in PAH2 affected binding of most aptamers apart
from P2-7 and P2-11 (Figure 4B). The double PAH2 mutant
F7V V14L failed to interact with any of the aptamers except
P2-7. These results thus corroborate and extend the impor-
tance of these PAH2 residues for the interaction with Mad
to other PAH2 interacting aptamers (29).
Two striking observations were made upon visual inspec-
tion of the PAH2 aptamers sequences. First, the strongest
PAH2 aptamer P2-2 shows homology to sequences of the
PAH2 SIDs from Pf1 and Mad family members. Second,
P2-3, P2-11 and P2-6 share a A[AV]X[VA][LV] motif and
show homology to SIDs from TIEG1 and TIEG2, Ume6,
HBP1 and BTEB4 (Figure 4C). This suggests that the
PAH2 domain of Sin3 can recruit two types of SIDs, Mad-
like high-affinity SIDs and moderate affinity SIDs with a
A[AV]X[VA][LV] motif.
Purification of TAP-tagged mSin3b and association
with NRL
Although a few peptide aptamers displayed homology to the
putative PAH2 interactors BTB5 and a BTB/POZ domain
containing protein 12 (Figure 4C), we embarked on a differ-
ent but complementary experimental strategy to identify
Sin3 interacting proteins by purifying a TAP-tagged Sin3b
complex from HEK 293 cells. Analysis of the purified
Sin3b complex by silver stain showed several bands which
were absent from a control purification using extract from
wild-type cells. To identify the composition of the Sin3b
complex preparation, nano LC-FT-ICR MS analysis was
performed (Figure 5A). As judged from % sequence coverage
and number of peptides per protein, HDAC1, HDAC2
and Sin3b were present at stoichiometric levels whereas
the histone-binding proteins RbAp46/48, HDAC1-binding
protein SDS3, RBP1, SAP130, breast cancer metastasis sup-
pressor BRMS1 and Sin3a were present in sub-stoichiometric
amounts (Figure 5B). These results suggest that we purified
a Sin3b sub-complex composed exclusively of Sin3b and
HDAC1/2 as well as a complete complex composed of Sin3a,
HDAC1/2 and the other known subunits. FT-MS (Fourier
transform-ion cyclotron resonance-mass spectroscopy) anal-
ysis also revealed mono-methylation on K386 of mSin3b, a
conserved lysine residue localized in the SDS3/HDAC inter-
action domain (Figure 5C).
In addition to proteins that are part of the Sin3/HDAC
complex, peptides matching the transcription factors Pf1
and Mad1 were identified that are known to interact with
the Sin3/HDAC complex. Thus this new tagging/proteomic
procedure can be used to identify interacting transcription
factors. NRL, a known transcription factor was also detected
in the FT-MS analysis, suggesting that it interacts with the
Sin3/HDAC complex. Visual inspection of the NRL amino
acid sequence revealed a short predicted a helical stretch
with a striking homology to aptamer P2-11 suggesting that
NRL and the PAH2 domain of Sin3b may indeed interact
(Figure 5D). To directly test an interaction between PAH2
and NRL, GST pull-down experiments were performed.
Extracts derived from cells transfected with myc-tagged
NRL were incubated with equal amounts of GST–PAH2 or
GST–PAH1 and GST beads. A specific interaction between
NRL and GST–PAH2, but not with GST–PAH1, could be
detected, providing biochemical evidence for a direct interac-
tion between NRL and the PAH2 domain of mSin3b
(Figure 5E).
Finally, we performed reporter assays to assess the func-
tional role of NRL region 125–150 in transcription. We trans-
fected the 293 HEK cells with GAL4 fused to NRL or NRL
region 125–150 in combination with a luciferase reporter
Figure 3. Analysis of the interaction between PAH1 and the FXXLVXLL motif in vitro. (A) Igg pull-down of P1-1 and P1-8. P1-1 and P1-8 were fused to ProtG
and incubated with GST fused to PAH1, PAH2, PAH1 single, double or triple mutant V7F, L14V and K39Q and washed extensively. Bound material was eluted,
separated on SDS–PAGE and stained using coomassie blue. (B) Alanine scan strategy. Every established mutants used are shown. (C) Igg pull-down of
FXXLVXLL mutants of P1-8. Every mutant of P1-8 were fused to ProtG and incubated with GST–PAH1. Bound material was eluted, separated on SDS–PAGE
and stained using coomassie blue. Upper panel depicts input of the different P1-8 mutants used while lower panel depicts the GST–PAH1 bound fraction after Igg
pull-down.
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plasmid containing five GAL4-binding sites. NRL trans-
activated the reporter gene in our settings in agreement
with other reports (Figure 5F) (30). In contrast, NRL region
125–150 has a reproducible repressed expression through
the domain that can bind to the Sin3b complex. One
prediction from these observations is that if Sin3b is involved
in repression, then the repression should be HDAC-activity
dependent. Therefore, we assessed the effect of TSA, a spe-
cific inhibitor of HDAC activity on repression. Whereas a
modest gain in transcriptional activity of full-length NRL
A
B
C
Figure 4. Analysis of the interaction of PAH2 aptamers. (A) PAH2 aptamers fused to G4AD were assayed in liquid culture to examine b-galactosidase activity
either in the presence G4DBD fused to PAH1 and PAH2. (B) b-Galactosidase assay of PAH2 aptamers in the presence of G4DBD fused to PAH2 single or
double mutant F7V and V14L. (C) Sequence alignment of P2-2 and P2-5 showing homology to the SID of Mad, Mad from Caenorrhabditis elegans and Pf1
(upper panel) Sequence alignment of P2-3, P2-6 inverted sequence and P2-11 matching the A[AV]X[VA][LV] motif conserved in Ume6, HBP1, BTEB4, TIEG1
and TIEG2 SIDs (middle panel). SID from potential PAH2 interacting proteins matching the A[AV]X[VA][LV] motif include residues 65–58 from BTB and
kelch domain containing protein 5 (accession no. Q96NJ5) include residues 1070–1063 from BTB/POZ domain containing protein 12 (accession no. Q8IY92)
(lower panel).
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could be observed upon TSA treatment, significant derepres-
sion by the NRL region 125–150 was observed suggesting
that the NRL region 125–150 does indeed associate with
HDAC to repress transcription.
In conclusion, the experiments described in this study
establish one interaction motif for PAH1 and two different
motifs for the PAH2 domain of the Sin3 transcriptional
co-repressor and revealed NRL as a novel Sin3 interacting
protein.
DISCUSSION
In this study we have used two different approaches to
identify PAH1 and PAH2 interacting proteins. By performing
an yeast two-hybrid screening of a peptide aptamer library we
have identified a small repertoire of peptides interacting
specifically either the PAH1 or PAH2 domain of mSin3b.
Two high-affinity PAH1-binding aptamers contained an
LVXLL motif. Very recently, a study by Shiio et al. (34)
revealed Sap25 as a new PAH1 interacting protein part of
the Sin3 complex (34). The Sin3 interacting region of
Sap25 contains an LXXLL motif with striking similarity to
the sequence of PAH1 aptamer identified in this study
(Figure 2C). Our findings thus corroborate and extend the
importance of the LXXLL motif for Sin3 recruitment.
Three PAH2-binding aptamers shared an A[AV]X
[VA][LV] motif included in Ume6 or Kruppel-like family
members. One high-affinity PAH2-binding aptamer contained
an LLXXA motif shown previously to be part of the SID of
Mad family members. A search with the A[AV]X[VA][LV]
motif yielded the BTB and kelch containing protein 5
(BKLHD5) and the BTB-POZ domain containing protein
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Figure 5. TAP-tagging purification of mSin3b and FT/MS analyses reveals NRL as a new PAH2 interacting protein. Stable cell line, TAP-tagging procedure and
FT/MS analysis have been described in another study (32). (A) Silver stained gel of purified mSin3b complex from HEK 293 cells. mSin3b is indicated with an
arrow. (B) FT-MS/MS analysis with all identified proteins and their respective peptide numbers and Mascot score. (C) FT-MS/MS profile of mSin3b peptide
with methylation on K386. (D) Sequence alignment of putative PAH2 SIDs of NRL (residues 125–150) with P2-11. (E) Western blot of a GST pull-down
experiment using myc-NRL, GST–PAH1 and GST–PAH2. After extensive washing, bound material was eluted, separated on SDS–PAGE and subjected to
western blotting using a-myc antibody. Lower panel depicts input form GST–PAH1 and GST–PAH2 used in this experiment on a SDS–PAGE and stained using
coomassie blue. (F) Reporter assays in 293 HEK cells. GAL4, GAL4-NRL or GAL4-NRL 125–150 were co-transfected with a firefly luciferase reporter under
the control of five GAL4-binding sites and a control Renilla luciferase plasmid. Ratio between firefly and Renilla luciferase activities was expressed in fold
relative to Gal4. Average and standard deviation of two experiments performed in duplicate are shown.
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12. Our results therefore suggest that BTB containing pro-
teins could potentially have a repressive function on tran-
scription through recruitment of the Sin3/HDAC complex.
Additional studies are required to test this prediction.
We had shown previously that introduction of PAH2 con-
tact residues Phe7, Val14 and Gln39 at their corresponding
position in PAH1 enabled a specific interaction with Mad, a
PAH2 interacting protein (29). We therefore hypothesized
that PAH1 residues Val7, Leu14 and Lys39 play an important
role in the specificity between PAH1 and PAH1 aptamers.
Conversely we hypothesized that PAH2 residues Phe7,
Val14 and Gln39 play an important role in the specificity
between PAH2 and PAH2 aptamers. The majority of the
identified PAH1 aptamers were indeed affected in their inter-
action with PAH1 when Val14 was introduced. Furthermore
the LVXLL-type aptamers were unable to bind to PAH1 upon
introduction of Val14 or Gln39. In contrast the majority of
PAH2 aptamers were strongly disturbed in their binding
when Val7 and Leu14 of PAH1 were introduced into PAH2
as shown previously for the Mad SID. We therefore speculate
that residues 7, 14 and 39 indeed play a determining role in
the specificity of interactions between PAH1 and PAH2 and
their respective interacting partners.
In a complementary approach to identify novel Sin3 inter-
acting proteins, we purified TAP-tagged mSin3b complex
stably expressed in HEK 293 cells and identified known
Sin3 complex subunits. We observed co-purification of
Sin3a, SDS3, RBP1 and SAP130. The approach also yielded
the co-purification of several transcription factors, such as
Mad and Pf1 as well as a novel protein, NRL zipper protein.
Mad and Pf1 are known Sin3 PAH2 interactors whereas NRL
a bZip transcription factor involved in the regulation of
rhodopsin gene activity had not been linked previously to
Sin3-dependent repression. Interestingly, reporter assays
have shown that amino acids 30–93 of NRL encompass a
minimal transactivation domain and that this domain has a
substantially higher activation potential than full-length
NRL or a fragment encompassing amino acids 30–143.
These results described previously suggested that amino
acids 93–143 can affect the degree of NRL transactivation
(30). Our observations that NRL can interact directly with
PAH2 and that the NRL regions 125–150 have HDAC-
dependent repressive activity are in line with a model in
which Sin3b is involved in regulation of gene expression
by NRL.
In conclusion we identified two interaction motifs for the
PAH2 domain, a Mad-like motif and an A[AV]X[VA][LV]
motif. We also identified one LVXLL-containing motif for
the interaction with the PAH1 domain. We reveal that one
PAH2 aptamer shows homology to a novel protein NRL
zipper which was identified using TAP-tagging purification
of mSin3b. Finally we show that the specificity of the identi-
fied aptamers for an interaction with either the PAH1 or PAH2
domain depends upon the amino acids at positions 7, 14 and 39
of PAH1 and PAH2, respectively. Thus, this study provides
new insights into the molecular determinants of the specificity
of PAH1 and PAH2 for their interacting partners. Unravelling
the structure of the PAH1 domain in complex with their natu-
ral binding partner and elucidation of the specificities of alpha
helical motifs ultimately will help to further uncover the
molecular basis of specific Sin3 complex formation.
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